Reg Waldeck | Vice President, Head Global Market Access
Bayer

Day 2 (3rd March) @ 10:00

Panel: Staying Agile in a Shifting Landscape: Rethinking Global Market Access in the MFN era

How are recent policy developments influencing pricing dynamics and launch sequencing? 

Are companies becoming more selective in where and when they launch, and how does this differ for rare & specialty products vs mass-market therapies? 

How do you manage pricing risk across interconnected markets without compromising long-term value?  

Jorge Arellano, Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence, BioMarin

Reg Waldeck, Vice President, Head Global Market Access, Bayer

×

Reg Waldeck / Panel: Staying Agile in a Shifting Landscape: Rethinking Global Market Access in the MFN era

Reg Waldeck, Vice President, Head Global Market Access,
Bayer

Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and...

Close

Marta Andreykiv, VP, Viatris

Gavin Lewis, Senior Vice President, Head of Value and Access, Novartis

×

Gavin Lewis / Panel: Staying Agile in a Shifting Landscape: Rethinking Global Market Access in the MFN era

Gavin Lewis, Senior Vice President, Head of Value and Access,
Novartis

Gavin originally was an undergraduate in Economics and Politics, before working for the Scottish Government as an Economist in the Health Department. After obtaining an MSc in Health Economics from York University, he joined the Pharmaceutical industry for Roche in the UK where he worked for over...

Close

Moderator: Iroda Jurabekova, Executive Director, Global Market Access, Oncology, Boehringer Ingelheim

Day 2 (3rd March) @ 13:20

Developments in access in the US

Reg Waldeck, Vice President, Head Global Market Access, Bayer

×

Reg Waldeck / Developments in access in the US

Reg Waldeck, Vice President, Head Global Market Access,
Bayer

Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and...

Close

Day 2 (3rd March) @ 15:10

Critical capabilities for leadership development: stakeholder management & influence

Moderator: Natalia Scherff, Leadership Coach, INSEAD, ICF PCC, Coach Scherff

Reg Waldeck, Vice President, Head Global Market Access, Bayer

×

Reg Waldeck / Critical capabilities for leadership development: stakeholder management & influence

Reg Waldeck, Vice President, Head Global Market Access,
Bayer

Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and...

Close

Iroda Jurabekova, Executive Director, Global Market Access, Oncology, Boehringer Ingelheim